View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

DOT/OST RIN: 2105-AE58 Publication ID: Fall 2017 
Title: Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Certain Schedule II Drugs to the Department of Transportation's Drug-Testing Panel and Certain Minor Amendments 
Abstract:

The rulemaking would harmonize the DOT drug-testing program regulations on urine testing with the revised Mandatory Guidelines established by the U.S. Department of Health and Human Services for Federal drug-testing programs. Specifically, this rulemaking would add hydrocodone, hydromorphone, oxymorphone, and oxycodone to its drug-testing panel; add methylenedioxyamphetamine (MDA) as an initial test analyte; and remove methylenedioxyethylamphetamine (MDEA) as a confirmatory test analyte. This rulemaking would also explore burden-reducing measures, including adding clarification to certain drug-testing program provisions, removing outdated information in the regulations that is no longer needed, and removing the requirement for employers and C/TPAs to submit blind specimens.

 
Agency: Department of Transportation(DOT)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
EO 13771 Designation: Not subject to, not significant 
CFR Citation: 49 CFR 40   
Legal Authority: 40 U.S.C. 102,01, 322, 5331    40 U.S.C. 31306 and 54101 et seq.   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  01/23/2017  82 FR 7771   
NPRM Comment Period End  03/24/2017 
Final Rule  11/00/2017 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL: www.regulations.gov   Public Comment URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Bohdan Baczara
Department of Transportation
Office of the Secretary
1200 New Jersey Ave, SE,
Washington, DC 20590
Phone:202-366-6364
Fax:202-366-3897
Email: bohdan.baczara@dot.gov